KSKazuto Suda

Kazuto Suda

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Kazuto Suda has a total of 132 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Serum growth differentiation factor 15: A novel biomarker for diagnostic and prognostic prediction in biliary atresia

    by Masataka Hida, Kazuto Suda, Takashi Fujimoto, Hiroki Goto, Hiroko Watayo, Yosuke Tsunoda, Masahiro Shimizu, Taishi Iwakami, Satoshi Nakano, Mitsuyoshi Suzuki, et al.

  • Reduction of urothelial umbrella cells and impairment of barrier function in neurogenic bladder: Identification of influencing factors

    by Takamasa Suzuki, Kazuto Suda, Rumi Arii, Haruna Kawano, Xuxuan Rao, Xinmeng Yuan, Jianqin Zhang, Masafumi Tanaka, Shiho Yoshida, Atsuyuki Yamataka, et al.

  • Open Access

    Preoperative factors possibly predictive of technical difficulty during interval laparoscopic appendectomy in pediatric patients

    by Yu Ebata, Kazuto Suda, Michiaki Ikegami, Yuichiro Miyake, Shiho Yoshida, Soichi Shibuya, Junya Ishii, Hisae Iida, Nana Nakazawa-Tanaka, Shuko Nojiri, et al.

  • Hepatoprotective Effects of Imeglimin Are Associated With Preserved Mitochondrial Bioenergetics and Reduced Oxidative Stress in a Murine Cholestasis Model

    by Hiroki Goto, Kazuto Suda, Takehiro Yasukawa, Takashi Fujimoto, Xuxuan Rao, Yosuke Tsunoda, Masataka Hida, Meng Xia, Chengri Piao, Jianqin Zhang, et al.

    Purpose: Biliary atresia is a cholestatic liver disease that causes persistent inflammation and reduces the hepatic reserve. New therapeutic concepts are crucial to improve native liver survival. We investigated whether imeglimin, a mitochondria‐targeting agent, has hepatoprotective effects on cholestatic liver disease using a murine bile duct ligation (BDL) model. Methods: BDL was performed in 4–5‐week‐old mice. After BDL, the mice received intraperitoneal imeglimin or vehicle injections. Sham‐operated mice received vehicle. Blood and liver samples were collected on days 7 and 14 for biochemical and histological analysis. Mitochondrial morphology was examined by transmission electron microscopy. Quantitative PCR and immunoblotting were performed for inflammation and mitochondrial stress markers. Metabolomic profiling was conducted using capillary electrophoresis–mass spectrometry. Transcriptome was analyzed by RNA sequencing. Seahorse assays, ATP quantification, and MitoSOX staining were used to evaluate mitochondrial function and oxidative stress. Results: Imeglimin improved survival after BDL, and reduced serum AST, ALT, and bilirubin levels. Tissue fibrosis and Col1a1 and Acta2 expression were attenuated in imeglimin‐treated livers. Glycolysis, amino acid metabolism, and mitochondrial electron transport activity were enhanced. Expression of genes associated with mitochondrial function, antioxidant defense, and metabolic regulation was upregulated. Mitochondrial morphology was preserved, and mitochondrial number and size increased. Imeglimin elevated oxygen consumption, extracellular acidification rates, and ATP levels of BDL mice livers, while reducing mitochondrial superoxide and oxidative protein modification by 4‐hydroxynonenal. Expression levels of Il1β , Il6 , and Tnf decreased. Conclusion: Imeglimin exerted hepatoprotective effects on BDL‐operated mice, which are associated with preserved mitochondrial bioenergetic function and reduced oxidative stress.


  • Open Access

    12-HHT is associated with epithelial barrier enhancement and reduced inflammatory responses in colon organoids of normoganglionosis in Hirschsprung’s disease

    by Kazuto Suda, Kumpei Abe, Yurina Nishimura, Masafumi Tanaka, Yuki Nagasako, Xuxuan Rao, Jianqin Zhang, Siyi Zeng, Kentaro Fujiwara, Shunsuke Yamada, et al.

    Purpose: Hirschsprung-associated enterocolitis remains a major postoperative complication of Hirschsprung’s disease (HD), and impaired epithelial barrier integrity has been proposed as a contributing factor. In this study, we investigated whether 12-hydroxyheptadecatrienoic acid (12-HHT), an endogenous leukotriene B4 receptor 2 (BLT2) agonist, is associated with epithelial barrier enhancement and reduced inflammatory responses in patient-derived colonic organoids. Methods: Normoganglionic specimens from rectal/rectosigmoid HD at pull-through (HD-N; n = 8) and transverse colon specimens from anorectal malformation (ARM) at colostomy closure (n = 10) were used to generate colonic organoids. Epithelia were isolated using ethylenediaminetetraacetic acid and subsequently embedded in Matrigel. Baseline expression of TJP1 , TJP2 , F11R (encoding junctional adhesion molecule-A), JAM2 , CLDN1 , CLDN3 , CLDN4 ) and LTB4R2 (encoding BLT2) was assessed by qPCR and immunoblotting. Organoids were then treated with 12-HHT (0.4, 2, or 10 μM) for 7 days, followed by qPCR. Additional experiments assessed cytokine expression ( IL1B , IL6 ) and TJPs after 24 h with tumor necrosis factor-α (TNF-α, 100 ng/mL) plus phosphate buffered saline or 12-HHT. Barrier function was evaluated using FITC–dextran influx assays. Results: HD-N and ARM organoids exhibited similar growth efficiencies. Baseline expression for F11R , JAM2 , CLDN1 , CLDN3 , CLDN4 , and LTB4R2 was significantly lower in HD-N than in ARM. TJPs were upregulated by 12-HHT at 2 and 10 μM in both groups, with stronger effects in ARM. In HD-N organoids, 10 μM 12-HHT suppressed TNF-α-induced IL1B and IL6 elevation mitigated tight junction proteins (TJPs) downregulation more effectively than 2 μM. 12-HHT attenuated TNF-α–induced FITC–dextran influx in HD-N organoids. Conclusion: 12-HHT is associated with epithelial barrier enhancement and reduced inflammatory responses in HD-N organoids.


  • Characteristics and environmental susceptibility of first-pass meconium microbiota in neonates with congenital intestinal atresia

    by Ayaka Fukada, Kazuto Suda, Hiroko Watayo, Daisuke Motooka, Tadashi Shinoda, Mari Tohya, Asuka Ishiyama, Yurina Nishimura, Kentaro Fujiwara, Takanori Ochi, et al.

  • Open Access

    Surgical paradox: Physiological activation and improved mood state during surgical work in pediatric surgeons

    by Hisae Iida, Kazuto Suda, Ayaka Adachi, Michiaki Ikegami, Hiroko Watayo, Kentaro Fujiwara, Takamasa Suzuki, Kumpei Abe, Ailing Hu, Hiroyuki Kobayashi, et al.

    Purpose: Pediatric surgeons often experience physical and psychological strain. However, surgery may provide motivation and fulfillment. To explore this dual nature of surgical work, we examined physiological and psychological stress responses of pediatric surgeons on surgical working days (SW) and nonsurgical working days (NSW). Methods: Nineteen pediatric surgeons participated in this cross-sectional study. Salivary cortisol, autonomic nervous activity using a wearable device (low/high heart rate ratio [LHR]), and total mood disturbance (TMD) score, calculated from subscales of the Profile of Mood States 2nd Edition (POMS2) as an index of mood state, were assessed at two time points: before and after surgery by the operator on SW (mean preoperative time: 11:16 AM; mean postoperative time: 2:18 PM) and at 08:00 and 17:00 on NSW. Data were analyzed using mixed linear models and univariate tests to evaluate the influence of sex, post-call status, experience, and surgical site. Results: In both SW and NSW (54 and 44 evaluation sessions from 19 pediatric surgeons, respectively), the post-work decrease in cortisol levels was smaller in SW than in NSW (p<0.05). LHR increased significantly after surgery (SW) but not in NSW (p<0.05), indicating a sympathetically activated state, particularly remarkable in post-call status compared with non-post-call status (p<0.05). TMD scores were lower in SW than in NSW (p5 years) had lower TMD scores for both SW and NSW (p<0.05). Conclusion: Despite physical and psychological demands, performing surgery was linked to reduced mood disturbance among pediatric surgeons.

  • Open Access

    Rapid assessment of systemic oxidative stress balance in pediatric acute scrotum using REDOXLIBRA

    by Masaki Ito, Kazuto Suda, Ayaka Adachi, Michiaki Ikegami, Masataka Hida, Meng Xia, Takamasa Suzuki, Risa Masuda, Masafumi Tanaka, Shunsuke Yamada, et al.

  • First comparison of open, laparoscopic, and robot-assisted laparoscopic retroperitoneal pyeloplasty for pediatric ureteropelvic junction obstruction at a single institution

    by Masafumi Tanaka, Hiroyuki Koga, Yuichiro Miyake, Shiho Yoshida, Kazuto Suda, Soichi Shibuya, Takanori Ochi, Naho Fujiwara, Rumi Arii, Geoffrey J. Lane, et al.

  • Open Access

    Anti-inflammatory effects of 12-HHT via epithelial barrier enhancement in colon organoids of normoganglionosis in Hirschsprung’s disease

    by Kazuto Suda, Kumpei Abe, Yurina Nishimura, Masafumi Tanaka, Yuki Nagasako, Xuxuan Rao, Jianqin Zhang, Siyi Zeng, Kentaro Fujiwara, Shunsuke Yamada, et al.

    Purpose: Hirschsprung-associated enterocolitis remains a major postoperative complication of Hirschsprung’s disease (HD), and impaired epithelial barrier integrity has been proposed as a contributing factor. In this study, we investigated whether 12-hydroxyheptadecatrienoic acid (12-HHT), an endogenous leukotriene B4 receptor 2 (BLT-2) agonist, enhances the epithelial barrier and exerts anti-inflammatory effects in patient-derived colonic organoids. Methods: Normoganglionic specimens from rectal/rectosigmoid HD at pull-through (HD-N; n = 8) and transverse colon specimens from anorectal malformation (ARM) at colostomy closure (n = 10) were used to generate colonic organoids. Epithelia were isolated using ethylenediaminetetraacetic acid and subsequently embedded in Matrigel. Baseline expression of TJP1 , TJP2 , F11R (encoding junctional adhesion molecule-A), JAM2 , CLDN1 , CLDN3 , CLDN4 ) and LTB4R2 (encoding BLT-2) was assessed by qPCR and immunoblotting. Organoids were then treated with 12-HHT (0.4, 2, or 10 μM) for 7 days, followed by qPCR. Additional experiments assessed cytokine expression ( IL1B , IL6 ) and TJPs after 24 h with tumor necrosis factor-α (TNF-α, 100 ng/mL) plus phosphate buffered saline or 12-HHT. Barrier function was evaluated using FITC–dextran influx assays. Results: HD-N and ARM organoids exhibited similar growth efficiencies. Baseline expression for F11R , JAM2 , CLDN1 , CLDN3 , CLDN4 , and LTB4R2 was significantly lower in HD-N than in ARM. TJPs were upregulated by 12-HHT at 2 and 10 μM in both groups, with stronger effects in ARM. In HD-N organoids, 10 μM 12-HHT suppressed TNF-α-induced IL1B and IL6 elevation mitigated tight junction proteins (TJPs) downregulation more effectively than 2 μM. 12-HHT attenuated TNF-α–induced FITC–dextran influx in HD-N organoids. Conclusion: 12-HHT may exert anti-inflammatory effects by integrating TJPs of HD-N.